Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

PMCF Study of the Axonics SNM System Model 5101 (R20) for the Indication of OAB

NCT: NCT06789406 · RECRUITING

NCT IDNCT06789406
StatusRECRUITING
Start Date2025-09-18
Completion2031-10

Brief Summary

Post-market clinical follow-up for continued assessment of safety and performance to confirm long-term outcomes of the Axonics SNM System INS Model 5101.

Frequently Asked Questions

What is PMCF Study of the Axonics SNM System Model 5101 (R20) for the Indication of OAB?

PMCF Study of the Axonics SNM System Model 5101 (R20) for the Indication of OAB is a clinical trial registered under NCT06789406. Current status: RECRUITING.

What is the status of NCT06789406?

The current status of NCT06789406 (PMCF Study of the Axonics SNM System Model 5101 (R20) for the Indication of OAB) is: RECRUITING.

When did PMCF Study of the Axonics SNM System Model 5101 (R20) for the Indication of OAB start?

PMCF Study of the Axonics SNM System Model 5101 (R20) for the Indication of OAB started on 2025-09-18.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑